Medical Review Board Meeting, Public Listening Session, 11423-11424 [E7-4468]
Download as PDF
Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices
Daytona Beach, Florida, United States of
America.
FOR FURTHER INFORMATION CONTACT: (1)
RTCA Secretariat, 1828 L Street, NW.,
Suite 805, Washington, DC 20036;
telephone (202) 833–9339; fax (202)
833–9434; Web site https://www.rtca.org;
(2) Joint Secretaries, Europe: Mr. Ross
Hannon, telephone +44 78807–46650, email: ross_hannon@binternet.com; US:
Mr. Michael DeWalt, telephone (206)
972–0170, e-mail:
mike.dewalt@certification.com.
Pursuant
to Section 10(a)(2) of the Federal
Advisory Committee Act (Pub. L. 92–
463, 5 U.S.C., Appendix 2), notice is
hereby given for a Special Committee
205/EUROCAE Working Group 71
meeting:
SUPPLEMENTARY INFORMATION:
Note: On arrival at ERAU please have
photo identification available (either a
passport, a drivers license bearing a
photograph or an identity card) to assist in
your badge being issued.
•
•
•
•
cprice-sewell on PROD1PC66 with NOTICES
•
14:58 Mar 12, 2007
Jkt 211001
Issued in Washington, DC, on March 7,
2007.
Francisco Estrada C.,
RTCA Advisory Committee.
[FR Doc. 07–1160 Filed 3–12–07; 8:45 am]
BILLING CODE 4910–13–M
DEPARTMENT OF TRANSPORTATION
The agenda will include:
March 19:
• Registration.
• New Attendees Introductory
Session.
• Sub-Group Meetings.
• Sub-Group Meeting Continue.
• Executive Committee/SG Chairs/
Secretaries Meeting.
March 20:
• Plenary: Chairmen’s Remarks and
Introductions, Review/Approve
Agenda and 4th Joint Plenary
Minutes.
• Issue List Status Report, Internet
and Serve Access Presentation.
• Sub-Group Report Ins and Q & A,
Other Reports, and Other
Documents.
• Sub-Group Meetings.
• Executive Committee/SG Chairs/
Secretaries Meeting.
March 21:
• Sub-Group Meetings.
• Plenary Session.
March 22:
• Sub-Group Meetings.
• Plenary Session.
• Executive Committee/SG Chairs/
Secretaries Meeting.
March 23:
• Plenary Session: Report Outs,
Evaluation of Papers.
• Sub-Group 3: Tool Qualification.
• Sub-Group 4: Model Based Design &
Verification.
• Sub-Group 5: Object Oriented
Technology.
• Sub-Group 6: Formal Methods.
• Sub-Group 7: Special
Considerations.
• Sub-Group 1: SCWG Document
Integration.
VerDate Aug<31>2005
• Closing Plenary Session (Other
Business, Date and Place of Next
Meeting, Meeting Evaluation,
Adjourn).
Attendance is open to the interested
public but limited to space availability.
With the approval of the chairmen,
members of the public may present oral
statements at the meeting. Persons
wishing to present statements or obtain
information should contact the person
listed in the FOR FURTHER INFORMATION
CONTACT section. Members of the public
may present a written statement to the
committee at any time.
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2007–27186]
Medical Review Board Meeting, Public
Listening Session
Federal Motor Carrier Safety
Administration (FMCSA), United States
Department of Transportation (DOT).
ACTION: Notice of Medical Review Board
(MRB) Meeting and Public Listening
Session.
AGENCY:
SUMMARY: FMCSA announces a meeting
and public listening session of the
Agency’s MRB. The MRB members will
continue deliberations about current
FMCSA medical standards, as well as
consider recommendations for new
science-based standards and guidelines
to ensure that the physical condition of
drivers is adequate to enable them to
safely operate commercial motor
vehicles (CMVs) in interstate commerce.
In accordance with the Federal
Advisory Committee Act (FACA), the
MRB meeting is open to the public.
DATES: The MRB meeting will be held
from 9 a.m. to 3:30 p.m. on April 25,
2007. The public may offer oral
comments and ask questions of the MRB
members relative to the medical and
scientific issues discussed from 1:30
p.m. to 3:30 p.m.
ADDRESSES: The MRB meeting will take
place at the Crown Plaza Hotel, 1375
South Broadway, Lexington, KY 40504–
2703. You may submit comments
identified by DOT Docket Management
System (DMS) Docket Number FMCSA–
2007–27186 using any of the following
methods:
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
11423
• Web Site: https://dmses.dot.gov/
submit. Follow the instructions for
submitting comments on the DOT
electronic docket site.
• Fax: 1–202–493–2251.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 400
Seventh Street, SW., Nassif Building,
Room PL–401, Washington, DC 20590–
0001.
• Hand Delivery: Room PL–401 on
the plaza level of the Nassif Building,
400 Seventh Street, SW., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
• Federal eRulemaking Portal: Go to
https://www.regulations.gov. Follow the
online instructions for submitting
comments.
Instructions: All submissions must
include the Agency name and docket
number for this notice. Note that all
comments received will be posted
without change to https://dms.dot.gov
including any personal information
provided. Please see the Privacy Act
heading for further information.
Docket: For access to the docket to
read background documents or
comments received, go to https://
dms.dot.gov at any time or Room PL–
401 on the plaza level of the Nassif
Building, 400 Seventh Street, SW.,
Washington, DC, between 9 a.m. and 5
p.m., Monday through Friday, except
Federal holidays. The DMS is available
24 hours each day, 365 days each year.
If you want acknowledgment that we
received your comments, please include
a self-addressed, stamped envelope or
postcard or print the acknowledgement
page that appears after submitting
comments on-line.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of our dockets by the
name of the individual submitting the
comment (or of the person signing the
comment, if submitted on behalf of an
association, business, labor union, etc.).
You may review the U.S. Department of
Transportation’s complete Privacy Act
Statement in the Federal Register
published on April 11, 2000 (65 FR
19477; Apr. 11, 2000). This information
is also available at https://dms.dot.gov.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary D. Gunnels, Chief, Physical
Qualifications Division, 202–366–4001,
FMCSA, Department of Transportation,
400 Seventh Street, SW., Washington,
DC 20590–0001. Office hours are from
8:30 a.m. to 5 p.m. Monday through
Friday, except Federal holidays.
Information on Services for Individuals
With Disabilities
For information on facilities or
services for individuals with disabilities
E:\FR\FM\13MRN1.SGM
13MRN1
11424
Federal Register / Vol. 72, No. 48 / Tuesday, March 13, 2007 / Notices
or to request special assistance at the
meeting, contact Kaye Kirby at 202–
366–4001.
SUPPLEMENTARY INFORMATION:
The preliminary agenda for the MRB
meeting:
0800–0900 Registration (Includes
Request for Comments).
0900–0905 Call to Order, Agenda
Review.
0905–0925 MRB Actions, (Diabetes &
Schedule II Medications).
0925–0945 Cardiovascular Disease.
0945–1015 Cardiovascular Disease
Expert Panel Recommendations.
1015–1100 MRB questions on
Cardiovascular Disease.
1100–1130 Deliberations on Evidence
Report & Panel Comments.
1130–1200 MRB Recommendations.
1200–1330 Lunch Break (Attendees
are responsible for their lunch).
1330–1530 Public Comment.
*Breaks will be announced on
meeting day and may be adjusted
according to schedule changes, other
listening session requirements.
Medical Review Board Meeting
cprice-sewell on PROD1PC66 with NOTICES
The U.S. Secretary of Transportation
announced on March 7, 2006, the five
medical experts who serve on FMCSA’s
MRB. Section 4116 of the Safe,
Accountable, Flexible, Efficient
Transportation Equity Act: A Legacy for
Users (SAFETEA–LU, Pub. L. 109–59)
requires the Secretary of Transportation
with the advice of the MRB to
‘‘establish, review, and revise medical
standards for operators of CMVs that
will ensure that the physical condition
of operators is adequate to enable them
to operate the vehicles safely.’’ FMCSA
is considering updates to the physical
qualification regulations of CMV
drivers, and the MRB will provide the
necessary science-based guidance to
establish realistic and responsible
medical standards.
The MRB operates in accordance with
FACA as announced in the Federal
Register (70 FR 57642, October 3, 2005).
The MRB is charged initially with the
review of all current FMCSA medical
standards (49 CFR 391.41), as well as
proposing new science-based standards
and guidelines to ensure that drivers
operating CMVs in interstate commerce,
as defined in CFR 390.5, are physically
capable of doing so.
Meeting Participation
Attendance is open to the interested
public, including medical examiners,
motor carriers, drivers, and
representatives of medical and scientific
associations. The public can ask
relevant questions of the MRB and
VerDate Aug<31>2005
14:58 Mar 12, 2007
Jkt 211001
comment about the information
presented to the MRB during the
listening session of the program, which
will be held 1:30 p.m.–3:30 p.m. Written
comments for the MRB meeting will
also be accepted beginning on March 27,
2007, and continuing until May 17,
2007, and should include the docket
number that is listed in the ADDRESSES
section. During the MRB meeting, oral
comments may be limited depending on
how many persons wish to comment;
and will be accepted on a first come,
first serve basis as requestors register at
the meeting. The comments must
directly address relevant medical and
scientific issues on the MRB meeting
agenda. For more information, view the
following Web site: https://
www.mrb.fmcsa.dot.gov.
Issued on: March 6, 2007.
John H. Hill,
Administrator.
[FR Doc. E7–4468 Filed 3–12–07; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket Nos. FMCSA–98–3637, FMCSA–00–
7165, FMCSA–00–7363, FMCSA–00–8203,
FMCSA–02–12844, FMCSA–02–12294,
FMCSA–04–19477]
Qualification of Drivers; Exemption
Renewals; Vision
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
SUMMARY: FMCSA previously
announced its decision to renew the
exemptions from the vision requirement
in the Federal Motor Carrier Safety
Regulations for these 45 individuals.
FMCSA has statutory authority to
exempt individuals from the vision
requirement if the exemptions granted
will not compromise safety. The Agency
has reviewed the comments submitted
in response to the previous
announcements and concluded that
granting these exemptions will provide
a level of safety that will be equivalent
to, or greater than, the level of safety
maintained without the exemptions for
these commercial motor vehicle (CMV)
drivers.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary D. Gunnels, Chief, Physical
Qualifications Division, (202) 366–4001,
maggi.gunnels@dot.gov, FMCSA,
Department of Transportation, 400
Seventh Street, SW., Room 8301,
Washington, DC 20590–0001. Office
hours are from 8:30 a.m. to 5 p.m.,
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
Monday through Friday, except Federal
holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online
through the Document Management
System (DMS) at https://dmses.dot.gov.
Background
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption for a 2year period if it finds ‘‘such exemption
would likely achieve a level of safety
that is equivalent to, or greater than, the
level that would be achieved absent
such exemption.’’ The statute also
allows the Agency to renew exemptions
at the end of the 2-year period. The
comment period ended on February 8,
2007.
Discussion of Comments
FMCSA received two comments in
these proceedings. The comments were
considered and discussed below.
Ms. Sachau believes that drivers with
impaired vision should not be driving
commercially because it makes the
roads much more dangerous.
A review of each record for safety
while driving with the respective vision
deficiencies over the past two years
indicates each applicant continues to
meet the vision exemption standards.
To evaluate the effect of these
exemptions on safety, FMCSA
considered not only the medical reports
about the applicants’ vision, but also
their driving records and experience
with the vision deficiency. To qualify
for an exemption from the vision
standard, FMCSA requires a person to
present verifiable evidence that he or
she has driven a commercial vehicle
safely with the vision deficiency for 3
years. Recent driving performance is
especially important in evaluating
future safety, according to several
research studies designed to correlate
past and future driving performance.
Results of these studies support the
principle that the best predictor of
future performance by a driver is his/her
past record of crashes and traffic
violations. Copies of the studies may be
found at docket number FMCSA–98–
3637.
Advocates for Highway and Auto
Safety (Advocates) expressed opposition
to FMCSA’s policy to grant exemptions
from the FMCSR, including the driver
qualification standards. Specifically,
Advocates: (1) Objects to the manner in
which FMCSA presents driver
information to the public and makes
safety determinations; (2) objects to the
Agency’s reliance on conclusions drawn
from the vision waiver program; (3)
E:\FR\FM\13MRN1.SGM
13MRN1
Agencies
[Federal Register Volume 72, Number 48 (Tuesday, March 13, 2007)]
[Notices]
[Pages 11423-11424]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-4468]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2007-27186]
Medical Review Board Meeting, Public Listening Session
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), United
States Department of Transportation (DOT).
ACTION: Notice of Medical Review Board (MRB) Meeting and Public
Listening Session.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces a meeting and public listening session of the
Agency's MRB. The MRB members will continue deliberations about current
FMCSA medical standards, as well as consider recommendations for new
science-based standards and guidelines to ensure that the physical
condition of drivers is adequate to enable them to safely operate
commercial motor vehicles (CMVs) in interstate commerce. In accordance
with the Federal Advisory Committee Act (FACA), the MRB meeting is open
to the public.
DATES: The MRB meeting will be held from 9 a.m. to 3:30 p.m. on April
25, 2007. The public may offer oral comments and ask questions of the
MRB members relative to the medical and scientific issues discussed
from 1:30 p.m. to 3:30 p.m.
ADDRESSES: The MRB meeting will take place at the Crown Plaza Hotel,
1375 South Broadway, Lexington, KY 40504-2703. You may submit comments
identified by DOT Docket Management System (DMS) Docket Number FMCSA-
2007-27186 using any of the following methods:
Web Site: https://dmses.dot.gov/submit. Follow the
instructions for submitting comments on the DOT electronic docket site.
Fax: 1-202-493-2251.
Mail: Docket Management Facility; U.S. Department of
Transportation, 400 Seventh Street, SW., Nassif Building, Room PL-401,
Washington, DC 20590-0001.
Hand Delivery: Room PL-401 on the plaza level of the
Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
Federal eRulemaking Portal: Go to https://
www.regulations.gov. Follow the online instructions for submitting
comments.
Instructions: All submissions must include the Agency name and
docket number for this notice. Note that all comments received will be
posted without change to https://dms.dot.gov including any personal
information provided. Please see the Privacy Act heading for further
information.
Docket: For access to the docket to read background documents or
comments received, go to https://dms.dot.gov at any time or Room PL-401
on the plaza level of the Nassif Building, 400 Seventh Street, SW.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The DMS is available 24 hours each day, 365
days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or postcard
or print the acknowledgement page that appears after submitting
comments on-line.
Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review the U.S. Department of Transportation's complete Privacy
Act Statement in the Federal Register published on April 11, 2000 (65
FR 19477; Apr. 11, 2000). This information is also available at https://
dms.dot.gov.
FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Chief, Physical
Qualifications Division, 202-366-4001, FMCSA, Department of
Transportation, 400 Seventh Street, SW., Washington, DC 20590-0001.
Office hours are from 8:30 a.m. to 5 p.m. Monday through Friday, except
Federal holidays.
Information on Services for Individuals With Disabilities
For information on facilities or services for individuals with
disabilities
[[Page 11424]]
or to request special assistance at the meeting, contact Kaye Kirby at
202-366-4001.
SUPPLEMENTARY INFORMATION:
The preliminary agenda for the MRB meeting:
0800-0900 Registration (Includes Request for Comments).
0900-0905 Call to Order, Agenda Review.
0905-0925 MRB Actions, (Diabetes & Schedule II Medications).
0925-0945 Cardiovascular Disease.
0945-1015 Cardiovascular Disease Expert Panel Recommendations.
1015-1100 MRB questions on Cardiovascular Disease.
1100-1130 Deliberations on Evidence Report & Panel Comments.
1130-1200 MRB Recommendations.
1200-1330 Lunch Break (Attendees are responsible for their lunch).
1330-1530 Public Comment.
*Breaks will be announced on meeting day and may be adjusted
according to schedule changes, other listening session requirements.
Medical Review Board Meeting
The U.S. Secretary of Transportation announced on March 7, 2006,
the five medical experts who serve on FMCSA's MRB. Section 4116 of the
Safe, Accountable, Flexible, Efficient Transportation Equity Act: A
Legacy for Users (SAFETEA-LU, Pub. L. 109-59) requires the Secretary of
Transportation with the advice of the MRB to ``establish, review, and
revise medical standards for operators of CMVs that will ensure that
the physical condition of operators is adequate to enable them to
operate the vehicles safely.'' FMCSA is considering updates to the
physical qualification regulations of CMV drivers, and the MRB will
provide the necessary science-based guidance to establish realistic and
responsible medical standards.
The MRB operates in accordance with FACA as announced in the
Federal Register (70 FR 57642, October 3, 2005). The MRB is charged
initially with the review of all current FMCSA medical standards (49
CFR 391.41), as well as proposing new science-based standards and
guidelines to ensure that drivers operating CMVs in interstate
commerce, as defined in CFR 390.5, are physically capable of doing so.
Meeting Participation
Attendance is open to the interested public, including medical
examiners, motor carriers, drivers, and representatives of medical and
scientific associations. The public can ask relevant questions of the
MRB and comment about the information presented to the MRB during the
listening session of the program, which will be held 1:30 p.m.-3:30
p.m. Written comments for the MRB meeting will also be accepted
beginning on March 27, 2007, and continuing until May 17, 2007, and
should include the docket number that is listed in the ADDRESSES
section. During the MRB meeting, oral comments may be limited depending
on how many persons wish to comment; and will be accepted on a first
come, first serve basis as requestors register at the meeting. The
comments must directly address relevant medical and scientific issues
on the MRB meeting agenda. For more information, view the following Web
site: https://www.mrb.fmcsa.dot.gov.
Issued on: March 6, 2007.
John H. Hill,
Administrator.
[FR Doc. E7-4468 Filed 3-12-07; 8:45 am]
BILLING CODE 4910-EX-P